These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution. Yang SS; Hearse DJ Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036 [TBL] [Abstract][Full Text] [Related]
29. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110 [TBL] [Abstract][Full Text] [Related]
31. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates. Bernard M; Menasche P; Canioni P; Fontanarava E; Grousset C; Piwnica A; Cozzone P J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746 [TBL] [Abstract][Full Text] [Related]
32. Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. Yano Y; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1987 Dec; 94(6):887-96. PubMed ID: 3682858 [TBL] [Abstract][Full Text] [Related]
33. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution. von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179 [TBL] [Abstract][Full Text] [Related]
34. [Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery]. Menasche P; Groussett C; Piwnica A Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1465-74. PubMed ID: 6322715 [TBL] [Abstract][Full Text] [Related]
36. Benefits of glucose and oxygen in multidose cold cardioplegia. Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987 [TBL] [Abstract][Full Text] [Related]
37. Protection of the ischemic myocardium: cold chemical cardioplegia, coronary infustates and the importance of cellular calcium control. Jynge P Thorac Cardiovasc Surg; 1980 Oct; 28(5):310-21. PubMed ID: 6161429 [TBL] [Abstract][Full Text] [Related]
38. The potential hazard of particulate contamination of cardioplegic solutions. Robinson LA; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859 [TBL] [Abstract][Full Text] [Related]